Pengaruh Ibu Bersalin Dengan Preeklamsia Terhadap Kejadian Resiko Tinggi Pada Bayi Baru Lahir Di RSD Dr. Soebandi Jember Tahun 2017

Subiastutik, Eni; Maryanti, Syiska Atik; Hafiyah, Shofiyatul

doi:10.25047/j-kes.v7i1.70

Cited by 2 publications

(3 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In a study conducted by Togakirar (2017), patients with severe preeclampsia who received methyldopa and nifedipine alone experienced improvements in proteinuria levels. The percentage of patients who experienced improvements in proteinuria after the use of methyldopa and nifedipine was 90% and 88 %, respectively (Subiastutik et al, 2019).…”

Section: The Antihypertensive Drug Evaluation To Clinical Outcome In ...mentioning

confidence: 99%

“…Evaluation of the use of antihypertensive drugs was carried out using the chi-square test to determine the correlation between the use of antihypertensive drugs and the condition of the baby's birth in mothers with preeclampsia. Subiastutik (2019) on the RSUD dr. Soebandi Jember January-December 2017, ot was found from total of 105 preeclampsia patients, 4 (3.81%) babies experienced IUFD.…”

Section: The Antihypertensive Drug Evaluation To Clinical Outcome In ...mentioning

confidence: 99%

See 1 more Smart Citation

Evaluation of the Antihypertensive Drugs in Preeclampsia Patients to Clinical Outcomes at Rsud Sekarwangi on 2021 Period

Rokhmah,

Zunita,

Septiani

2023

View full text Add to dashboard Cite

Preeclampsia is a pregnancy complication with several symptoms, such as hypertension, proteinuria, and edema. Such symptoms occur in pregnant women after the gestational age reaches 20 weeks. Preeclampsia is divided into mild preeclampsia (PER) and severe preeclampsia (PEB). Antihypertensive drugs are used to lower blood pressure and proteinuria levels in patients with preeclampsia. The purpose of this study was to obtain a profile of antihypertensive drugs and monitor changes in clinical outcomes in patients with preeclampsia. This was a retrospective cross-sectional study using secondary data from the medical records of preeclampsia patients. Of the 54 patients who met the inclusion criteria with the age at which most preeclampsia was 21–35 years old, 33 (61.11%) patients and 32 (59.62%) patients had PEB. The most widely used antihypertensive drug was a combination of methyldopa and nifedipine, with 27 (50%) patients receiving combination therapy. After treatment with antihypersensitive drugs, 50 (92.60%) patients experienced a decrease in blood pressure, 45 (83.33%) patients experienced a decrease in proteinuria levels, and 45 (83.33%) patients had normal birth conditions. Antihypertensive treatment for preeclampsia patients has a relationship with a decrease in the patient’s blood pressure (p-value = 0,007), but there was no relationship with a decrease in proteinuria levels (p-value = 0,660) and condition of baby birth (p-value = 0,446). Keyword: Preeclampsia; Antihypertensive Drugs; Clinical Outcomes

show abstract

Section: The Antihypertensive Drug Evaluation To Clinical Outcome In ...mentioning

confidence: 99%

Section: The Antihypertensive Drug Evaluation To Clinical Outcome In ...mentioning

confidence: 99%

Evaluation of the Antihypertensive Drugs in Preeclampsia Patients to Clinical Outcomes at Rsud Sekarwangi on 2021 Period

Rokhmah,

Zunita,

Septiani

2023

View full text Add to dashboard Cite

show abstract

“…Terdapat korelasi dengan hasil uji hipotesis BBLR. Koefisien kontingensi (CC), di sisi lain, adalah 0,218, menunjukkan bahwa ada hubungan yang kecil atau lemah tapi jelas antara preeklamsia ibu dan terjadinya BBLR 8 .…”

Section: ) Hasil Peneletian Setelah Dilakukan Telaah 20 Jurnalunclassified

Komplikasi Pada Kehamilan, Persalinan, Nifas dan Bayi Baru Lahir: Literature Review

Bayuana,

Anjani,

Nurul

et al. 2023

JWK

View full text Add to dashboard Cite

Kehamilan risiko tinggi adalah keadaan yang dapat mempengaruhi kondisi ibu maupun janin saat kehamilan apabila dilakukan tatalaksana sama seperti kehamilan normal. Risiko tinggi atau komplikasi kebidanan pada kehamilan merupakan keadaan penyimpangan dari normal, yang secara langsung menyebabkan kesakitan dan kematian ibu maupun bayi. Tujuan penelitian untuk mengetahui faktor resiko tinggi pada kehamilan, persalinan, nifas, dan BBL. Metode yang dipergunakan pada studi ini ialah menganalisis faktor risiko dengan mempergunakan kajian atau tinjauan literatur dengan mencari jurnal ataupun artikel yang relavansi pada resiko tinggi pada kehamilan, persalinan, nifas, dan BBL. Sumber tinjauannya mempergunakan media elektronik dari berbagai pangkalan data diantaranya Google Scholar serta Sience Direct yang dipublikasikannya dalam jangka waktu tahun 2018-2022. Hasil dari mentelaah beberapa jurnal didapatlan hasil review beberapa faktor resiko tinggi pada kehamilan, persalinan, nifas, dan BBL. Kesimpulannya, hamil resiko tinggi dapat dipengaruhi oleh usia, paritas, riwayat abortus, usia kehamilan < 2 tahun, dan tinggi badan < 145 cm. selain itu faktor resiko tinggi lainnya juga dipengaruhi oleh pendidikan dan pekerjaan. Oleh karena itu perlu dilakukan peningkatan penilaian risiko tinggi dengan melakukan deteksi dini komplikasi dan juga memanfaatkan teknologi yang ada dalam mendukung kesejahteraan ibu dan bayi selama kehamilan, persalinan, nifas dan bayi baru lahir

show abstract

Pengaruh Ibu Bersalin Dengan Preeklamsia Terhadap Kejadian Resiko Tinggi Pada Bayi Baru Lahir Di RSD Dr. Soebandi Jember Tahun 2017

Cited by 2 publications

References 1 publication

Evaluation of the Antihypertensive Drugs in Preeclampsia Patients to Clinical Outcomes at Rsud Sekarwangi on 2021 Period

Evaluation of the Antihypertensive Drugs in Preeclampsia Patients to Clinical Outcomes at Rsud Sekarwangi on 2021 Period

Komplikasi Pada Kehamilan, Persalinan, Nifas dan Bayi Baru Lahir: Literature Review

Contact Info

Product

Resources

About